Evidence map›Paper›PMID 38017024›Full record

SynthesisScientific data2023

A proteomic meta-analysis refinement of plasma extracellular vesicles.

Milene C Vallejo, Soumyadeep Sarkar, Emily C Elliott, Hayden R Henry, Samantha M Powell, Ivo Diaz Ludovico, Youngki You, Fei Huang, Samuel H Payne, Sasanka Ramanadham and 4 more

Open access · goldAbstract readMeta-Analysis
In one paragraph

Synthesis in Scientific data, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 1 country.

Milene C VallejoDepartment of Biology, Brigham Young University, Provo, UT, 84602, USA.
Soumyadeep SarkarBiological Sciences Division, Pacific Northwest National Laboratory, Richland, WA, 99352, USA.ORCID 0000-0002-1928-1848
Emily C ElliottBiological Sciences Division, Pacific Northwest National Laboratory, Richland, WA, 99352, USA.
Hayden R HenryBiological Sciences Division, Pacific Northwest National Laboratory, Richland, WA, 99352, USA.
Samantha M PowellBiological Sciences Division, Pacific Northwest National Laboratory, Richland, WA, 99352, USA.ORCID 0000-0003-2670-0024
Ivo Diaz LudovicoBiological Sciences Division, Pacific Northwest National Laboratory, Richland, WA, 99352, USA.
Youngki YouBiological Sciences Division, Pacific Northwest National Laboratory, Richland, WA, 99352, USA.
Fei HuangDepartment of Medicine, The University of Chicago, Chicago, IL, 60637, USA.
Samuel H PayneDepartment of Biology, Brigham Young University, Provo, UT, 84602, USA.ORCID 0000-0002-8351-1994
Sasanka RamanadhamDepartment of Cell, Developmental, and Integrative Biology, and Comprehensive Diabetes Center, University of Alabama at Birmingham, Birmingham, AL, 35294, USA.
Emily K SimsDepartment of Pediatrics, Center for Diabetes and Metabolic Diseases, Indiana University School of Medicine, Indianapolis, IN, 46202, USA.ORCID 0000-0002-4393-954X
Thomas O MetzBiological Sciences Division, Pacific Northwest National Laboratory, Richland, WA, 99352, USA.ORCID 0000-0001-6049-3968
Raghavendra G MirmiraDepartment of Medicine, The University of Chicago, Chicago, IL, 60637, USA.
Ernesto S NakayasuBiological Sciences Division, Pacific Northwest National Laboratory, Richland, WA, 99352, USA. ernesto.nakayasu@pnnl.gov.ORCID 0000-0002-4056-2695
Pacific Northwest National Laboratory · USBrigham Young University · USUniversity of Chicago · USIndiana University School of MedicineUniversity of Alabama at Birmingham · US

Funding

Pilot and Feasibility ProgramP30DK020595 · NIDDK · UNIVERSITY OF CHICAGO · PI RONALD N COHEN · 2013 to 2026
$20.9M
Transcriptional Mechanisms Governing Beta Cell DifferentiationR01DK060581 · NIDDK · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI Raghavendra G Mirmira · 2002 to 2026
$8.5M
The Integrated Stress Response in Human Islets During Early T1DU01DK127786 · NIDDK · UNIVERSITY OF CHICAGO · PI EVANS-MOLINA, CARMELLA, MIRMIRA, RAGHAVENDRA G · 2020 to 2025
$7.1M
Implications of Changes in Islet Exosomal Cargo in Type 1 DiabetesR01DK133881 · NIDDK · INDIANA UNIVERSITY INDIANAPOLIS · PI EVANS-MOLINA, CARMELLA, MIRMIRA, RAGHAVENDRA G · 2022 to 2025
$2.7M
iPLA2beta-mediated alternative splicing and -cell death in type 1 diabetesR01DK126444 · NIDDK · UNIVERSITY OF VIRGINIA · PI CHALFANT, CHARLES E., EIZIRIK, DECIO LAKS · 2021 to 2024
$2.0M
Beta cell extracellular vesicles in health and diseaseR01DK121929 · NIDDK · INDIANA UNIVERSITY INDIANAPOLIS · PI SIMS, EMILY K · 2020 to 2024
$2.0M
NIDDK NIH HHS R01 DK060581NIDDK NIH HHS R01 DK121929NIDDK NIH HHS R01 DK126444NIDDK NIH HHS R01 DK133881NIDDK NIH HHS U01 DK127786
6 · The paper itself

Abstract

Extracellular vesicles play major roles in cell-to-cell communication and are excellent biomarker candidates. However, studying plasma extracellular vesicles is challenging due to contaminants. Here, we performed a proteomics meta-analysis of public data to refine the plasma EV composition by separating EV proteins and contaminants into different clusters. We obtained two clusters with a total of 1717 proteins that were depleted of known contaminants and enriched in EV markers with independently validated 71% true-positive. These clusters had 133 clusters of differentiation (CD) antigens and were enriched with proteins from cell-to-cell communication and signaling. We compared our data with the proteins deposited in PeptideAtlas, making our refined EV protein list a resource for mechanistic and biomarker studies. As a use case example for this resource, we validated the type 1 diabetes biomarker proplatelet basic protein in EVs and showed that it regulates apoptosis of β cells and macrophages, two key players in the disease development. Our approach provides a refinement of the EV composition and a resource for the scientific community.

Indexed as

Extracellular VesiclesProteomicsAnimalsAntigens, CDBiomarkersDatasets as TopicHumansProteinsSignal TransductionAntigens, CDBiomarkersProteins

Identifiers

PMID38017024
PMCPMC10684639
OpenAlexW4389086773

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.